Vaxcyte, Inc.Vaxcyte, Inc.Vaxcyte, Inc.

Vaxcyte, Inc.

No trades
See on Supercharts
Market capitalization
‪6.79 B‬USD
−4.21USD
‪−402.27 M‬USD
‪102.89 M‬
Beta (1Y)
0.38

About Vaxcyte, Inc.

CEO
Grant E. Pickering
Headquarters
San Carlos
Employees (FY)
254
Founded
2013
ISIN
US92243G1085
FIGI
BBG009PHHPL8
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PCVX is 60.62 USD — it has decreased by 2.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vaxcyte, Inc. stocks are traded under the ticker PCVX.
Vaxcyte, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
PCVX stock is 3.05% volatile and has beta coefficient of 0.38. Check out the list of the most volatile stocks — is Vaxcyte, Inc. there?
One year price forecast for Vaxcyte, Inc. has a max estimate of 113.00 USD and a min estimate of 95.00 USD.
PCVX earnings for the last quarter are −0.91 USD whereas the estimation was −0.84 USD which accounts for −8.64% surprise. Estimated earnings for the next quarter are −1.05 USD. See more details about Vaxcyte, Inc. earnings.
Yes, you can track Vaxcyte, Inc. financials in yearly and quarterly reports right on TradingView.
PCVX stock has fallen by 4.22% compared to the previous week, the month change is a 10.76% fall, over the last year Vaxcyte, Inc. has showed a 38.21% increase.
PCVX net income for the last quarter is ‪−180.80 M‬ USD, while the quarter before that showed ‪−92.66 M‬ USD of net income which accounts for −95.11% change. Track more Vaxcyte, Inc. financial stats to get the full picture.
Today Vaxcyte, Inc. has the market capitalization of ‪6.59 B‬, it has decreased by 0.53% over the last week.
No, PCVX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PCVX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vaxcyte, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PCVX reached its all-time high on Feb 28, 2024 with the price of 82.04 USD, and its all-time low was 15.51 USD and was reached on May 11, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 254.00 employees. See our rating of the largest employees — is Vaxcyte, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vaxcyte, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vaxcyte, Inc. stock shows the buy signal. See more of Vaxcyte, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Vaxcyte, Inc. future price: according to them, PCVX price has a max estimate of 113.00 USD and a min estimate of 95.00 USD. Read a more detailed Vaxcyte, Inc. forecast: see what analysts think of Vaxcyte, Inc. and suggest that you do with its stocks.